ethinyl estradiol has been researched along with Premenstrual Dysphoric Disorder in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simoni, MK; Yonkers, KA | 1 |
| Eisenlohr-Moul, TA; Girdler, SS; Johnson, JL; Rubinow, DR; Schmidt, PJ | 1 |
| Cheng, W; Fu, Y; Li, L; Mi, W; Sun, L; Wang, J; Xie, S; Zhang, H; Zhang, J | 1 |
1 review(s) available for ethinyl estradiol and Premenstrual Dysphoric Disorder
| Article | Year |
|---|---|
Premenstrual disorders.
Topics: Androstenes; Cognitive Behavioral Therapy; Complementary Therapies; Diagnostic and Statistical Manual of Mental Disorders; Ethinyl Estradiol; Exercise; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Ovariectomy; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Risk Factors; Salpingectomy; Selective Serotonin Reuptake Inhibitors | 2018 |
2 trial(s) available for ethinyl estradiol and Premenstrual Dysphoric Disorder
| Article | Year |
|---|---|
Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Premenstrual Dysphoric Disorder; Treatment Outcome; Young Adult | 2017 |
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study].
Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menorrhagia; Metrorrhagia; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Safety; Severity of Illness Index; Treatment Outcome | 2014 |